Chronotherapy of colorectal cancer

REFERENCES

• Lévi F. Cancer Chronotherapy. J. Pharm. Pharmacol. 1999; Aug(51)299–331
   Google Scholar
• Lévi F. Physiology and Pharmacology of Biological Rhythms. Chap. 11: Cancer Chemotherapy. Handbook of Experimental Pharmacology, P.H. Redfern, B. Lemmer. Springer, Berlin 1997; Vol. 125: 299–331
   Google Scholar
• Burns E.R., Beland S.S. Effect of Biological Time on the Determination of the LD50 of 5-Fluorouracil in Mice. Pharmacology 1984; 28: 296–300
   PubMedGoogle Scholar
• Ohdo S., Makinosumi T., Ishizaki T., Yukawa E., Higuchi S., Nakano S., Ogawa N. Cell Cycle-Dependent Chronotoxicity of Irinotecan Hydrochloride in Mice. J. Pharmacol. Exp. Ther. 1997; 283: 1383–1388
   PubMed Web of Science ®Google Scholar
• Filipski, E.; Lévi, F.; Vadrot, N.; Li, X.M.; Mormont, C.; Lemaigre, G.; Mahjoubi, M. In Circadian Changes in Irinotecan Toxicity in Mice, Proceedings of the 88th Annual Meeting of American Association of Cancer Research, San Diego, CA, April 12–16, 1997; Vol. 38 (abstr. #2048).
   Google Scholar
• D'attino, R. M.; Filipski, E. G.; Granda, T.; Vrignaud, P.; Garufi, C.; Terzoli, E.; Bissery, M. C.; Lévi, F. Circadian Optimization of Irinotecan and Oxaliplatin Efficacy in Mice with Glasgow Osteosarcoma. Br. J. Cancer, in press.
   Google Scholar
• Lévi F., Soussan A., Adam R., Caussanel J.P., Metzger G., Jasmin C., Bismuth H., Smolensky M., Misset J.L. A Phase I–II Trial of Five-Day Continuous Intravenous Infusion of 5-Fluorouracil Delivered at Circadian Rhythm Modulated Rate in Patients with Metastatic Colorectal Cancer. J. Infus. Chemother. 1995; 5(3)153–158
   PubMedGoogle Scholar
• Bjarnason G., Kerr I., Doyle N., Macdonald M., Sone M. Phase I Study of 5-Fluorouracil and Leucovorin by a 14-Day Circadian Infusion in Metastatic Adenocarcinoma Patients. Cancer Chemother. Pharmacol. 1993; 33: 221–228
   PubMedGoogle Scholar
• Garufi C., Lévi F., Aschelter A., Giunta S., Pace R., Nistico C., Tropea F., Cardamone I., Silecchia G., Terzoli E. A Phase I Trial of Five Day Chronomodulated Infusion of 5-Fluorouracil and l-Folinic Acid in Patients with Metastatic Colorectal Cancer. Eur. J. Cancer 1997; 33(10)1566–1571
   PubMedGoogle Scholar
• Curé H., Chevalier V., Adenis A., Tubiana-Mathieu N., Niezgodzki G., Kwiatkowski F., Pezet D., Perpoint B., Coudert B., Focan C., Levi F., Chipponi J., Chollet P. Phase II Trial of Chronomodulated Infusion of High-Dose 5-Fluorouracil and l-Folinic Acid in Previously Untreated Patients with Metastatic Colorectal Cancer. J. Clin. Oncol., in press
   Google Scholar
• Adler S., Lang S., Langenmayer I., Eibl-Eisbesfeldt B., Rump W., Emmerich B., Hallek M. Chronotherapy with 5-Fluorouracil and Folinic Acid in Advanced Colorectal Carcinoma. Results of a Chronopharmacologic Phase I Trial. Cancer 1994; 73(12)2905–2912
   PubMedGoogle Scholar
• Falcone A., Allegrini G., Antonuzzo A., Brunetti I., Pfanner E., Lencioni M., Masi G., Danesi R., Del Tacca M., Conte P. Infusion of Fluorouracil and Leucovorin: Effects of the Timing and Semi-intermittency of Drug Delivery. Oncology 1999; 57(3)195–201
   PubMedGoogle Scholar
• Caussanel J.P., Lévi F., Brienza S., Misset J.L., Itzhaki M., Adam R., Milano G., Hecquet B., Mathé G. Phase I Trial of 5-Day Continuous Infusion of Oxaliplatinum at Circadian-Modulated Vs. Constant Rate. J. Natl Cancer Inst. 1990; 82: 1046–1050
   PubMed Web of Science ®Google Scholar
• Lévi F., Perpoint B., Garufi C., Focan C., Chollet P., Deprés-Brummer P., Zidani R., Brienza S., Itzhaki M., Iacobelli S., Kunstlinger F., Gastiaburu J., Misset J.L. Oxaliplatin Activity Against Metastatic Colorectal Cancer. A Phase II Study of 5-Day Continuous Venous Infusion at Circadian Rhythm Modulated Rate. Eur. J. Cancer 1993; 29(9)1280–1284
   Web of Science ®Google Scholar
• Abigerges D., Chabot G., Armand J.P., Hérait P., Gouyette A., Gandia D. Phase I and Pharmacological Studies of the Camptothecin Analog Irinotecan Administered Every 3 Weeks in Cancer Patients. J. Clin. Oncol. 1995; 13(1)210–221
   PubMedGoogle Scholar
• Giacchetti S., Zidani R., Goldwasser F., Brezault-Bonnet C., Tigaud J.M., Mormont C., Montembault S., Misset J.L., Lévi F. Chronomodulated CPT-11. A Pilot Study. Proc. Am. Soc. Clin. Oncol. 1999; 18: 259a, (abstr. 996)
   Google Scholar
• Giacchetti S., Curé H., Adenis A., Tubiana N., Vernillet L., Messali L., Mille D., Germa C., Gayet C., Chollet P., Lévi F. Randomized Multicenter Trial of Irinotecan Chronomodulated Versus Standard Infusion in Patients with Metastatic Colorectal Cancer. Proc. Am. Soc. Clin. Oncol. 2001, (abstr. 2218)
   Google Scholar
• Lévi F., Misset J.L., Brienza S., Adam R., Metzger G., Itzakhi M., Caussanel J.P., Kunstlinger F., Lecouturier S., Descorps-Declère A., Jasmin C., Bismuth H., Reinberg A. A Chronopharmacologic Phase II Clinical Trial with 5-Fluorouracil, Folinic Acid and Oxaliplatin Using an Ambulatory Multichannel Programmable Pump. High Antitumor Effectiveness Against Metastatic Colorectal Cancer. Cancer 1992; 69: 893–900
   PubMed Web of Science ®Google Scholar
• Natoli C., Martino M., Irtelli L., D'ostilio N., Basilico L., Iacobelli S. Chronomodulated Infusion of 5-Fluorouracil, Folinic Acid and Carboplatin in Colorectal Cancer: A Pilot Study. Anticancer Res. 1995; 15(6B)2841–2842
   PubMedGoogle Scholar
• Focan C., Kreutz F., Focan-Henrard D., Moeneclaey N. Chronotherapy with 5-Fluorouracil, Folinic Acid and Carboplatin for Metastatic Colorectal Cancer; an Interesting Therapeutic Index in a Phase II Trial. Eur. J. Cancer 2000; 36(3)341–347
   PubMedGoogle Scholar
• Marsh R., Chu N., Vauthey J., Mendenhall W., Lauwers G., Bewsher C., Copeland E. Preoperative Treatment of Patients with Locally Advanced Unresectable Rectal Adenocarcinoma Utilizing Continuous Chronobiologically Shaped 5-Fluorouracil Infusion and Radiation Therapy. Cancer 1996; 78(2)217–225
   PubMedGoogle Scholar
• Shelton, C.; Schneider, B.; Rich, T. A Pilot Study of Chronomodulated Infusional 5-FU Chemoradiation. (Submitted).
   Google Scholar
• Giacchetti S., Perpoint B., Zidani R., Le Bail N., Faggiuolo R., Focan C., Chollet P., Llory J.F., Letourneau Y., Coudert B., Bertheault-Cvitkovic F., Larregain-Fournier D., Le Rol A., Walter S., Adam R., Misset J.L., Lévi F. Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First Line Treatment of Metastatic Colorectal Cancer. J. Clin. Oncol. 2000; 18(1)136–147, for The International Organization of Cancer
   PubMed Web of Science ®Google Scholar
• Lévi F., Zidani R., Vannetzel J.M., Perpoint B., Focan C., Faggiuolo R., Chollet P., Garufi C., Itzhaki M., Dogliotti L., Iacobelli S., Adam R., Kunstlinger F., Gastiaburu J., Bismuth H., Jasmin C., Misset J.L. Chronomodulated Versus Fixed Infusion Rate Delivery of Ambulatory Chemotherapy with Oxaliplatin, 5-Fluorouracil and Folinic Acid in Patients with Colorectal Cancer Metastases. A Randomized Multiinstitutional Trial. J. Natl Cancer Inst. 1994; 86: 1608–1617
   PubMed Web of Science ®Google Scholar
• Lévi F., Zidani R., Misset J.L. Randomized Multicentre Trial of Chronotherapy with Oxaliplatin, Fluorouracil, and Folinic Acid in Metastatic Colorectal Cancer. Lancet 1997; 350: 681–686, for The International Organization for Cancer Chronotherapy
   PubMed Web of Science ®Google Scholar
• Brienza S., Lévi F., Valori V., Bertheault-Cvitkovic F., Deprés-Brummer P., Lecouturier S., Kunstlinger F., Adam R., Misset J.L., Bismuth H. Intensified (Every 2 Weeks) Chronotherapy with 5-Fluorouracil (5-FU), Folinic Acid (FA) and Oxaliplatin (l-OHP) in Previously Treated Patients with Metastatic Colorectal Cancer. Proc. Am. Soc. Clin. Oncol. 1993; 12: 197, (abstr. 577)
   Google Scholar
• Bertheault-Cvitkovic F., Jami A., Ithzaki M., Deprés-Brummer P., Brienza S., Adam R., Bismuth H., Misset J.L., Lévi F. Biweekly Dose Intensification of Circadian Chronotherapy with 5-Fluorouracil, Folinic Acid and Oxaliplatin in Patients with Metastatic Colorectal Cancer. J. Clin. Oncol. 1996; 14(11)2950–2958
   PubMedGoogle Scholar
• Lévi F., Zidani R., Brienza S., Dogliotti L., Perpoint B., Rotarski M., Letourneau Y., Llory J.F., Chollet P., Le Rol A., Focan C. A Multicenter Evaluation of Intensified Ambulatory Chronomodulated Chemotherapy with Oxaliplatin, Fluorouracil and Leucovorin as Initial Freatment of Patients with Metastatic Colorectal Cancer. Cancer 1999; 85(12)2532–2540, for The International Organization for Cancer Chronotherapy
   PubMedGoogle Scholar
• Bismuth H., Adam R., Lévi F., Farabos C., Waechter F., Castaing D., Majno P., Engerran L. Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant Chemotherapy. Ann. Surg. 1996; 224(4)509–522
   PubMed Web of Science ®Google Scholar
• Adam R., Avisar E., Ariche A., Lévi F., Giacchetti S., Azoulay D., Castaing D., Delgado M., Guinet F., Bismuth H. Five Years Survival After Neoadjuvant Therapy for Nonresectable Colorectal Liver Metastases. Ann. Surg. Oncol. 2001; 8: 347–353
   PubMed Web of Science ®Google Scholar
• Giacchetti S., Itzhaki M., Gruia G., Adam R., Zidani R., Depres-Brummer P., Bleuzen P., Bertheault-Cvitkovic F., Kunstlinger F., Brienza S., Jasmin C., Alafaci E., Reynes M., Bismuth H., Misset J.L., Lévi F. Long Term Survival of Patients with Unresectable Colorectal Liver Metastases Following Infusional Chemotherapy with 5-Fluorouracil, Folinic Acid, Oxaliplatin and Surgery. Ann. Oncol. 1999; 10: 1–7
   Google Scholar